News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,098 Results
Type
Article (2576)
Company Profile (45)
Press Release (37476)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14192)
Career Advice (78)
Deals (2108)
Drug Delivery (9)
Drug Development (4144)
Employer Resources (10)
FDA (443)
Job Trends (782)
News (20272)
Policy (1057)
Tag
Academia (144)
Allergies (7)
Alliances (3491)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (324)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (82)
Cervical cancer (2)
Clinical research (3437)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (419)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (488)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (41)
Earnings (4501)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6405)
Executive appointments (134)
FDA (588)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (167)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (708)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1003)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (314)
Medtech (315)
Mergers & acquisitions (1220)
Metabolic disorders (72)
Multiple sclerosis (23)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (354)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (18)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5876)
Pharmaceutical (5)
Phase 1 (1474)
Phase 2 (1702)
Phase 3 (915)
Pipeline (392)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (425)
Recruiting (5)
Regulatory (916)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (498)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (6)
Last 7 days (43)
Last 30 days (142)
Last 365 days (2417)
2026 (217)
2025 (2438)
2024 (2610)
2023 (2859)
2022 (3751)
2021 (4050)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1947)
Australia (307)
California (1602)
Canada (241)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4016)
Florida (65)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (570)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (81)
North Carolina (131)
Northern California (781)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (653)
Tennessee (4)
Texas (152)
United States (3207)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,098 Results for "sagimet biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sagimet Biosciences Announces Participation in Two Upcoming February 2026 Investor Conferences
February 5, 2026
·
1 min read
Press Releases
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
December 17, 2025
·
8 min read
Press Releases
Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference
January 8, 2026
·
5 min read
Press Releases
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference
November 21, 2025
·
1 min read
Press Releases
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination
December 18, 2025
·
7 min read
Press Releases
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
October 15, 2025
·
2 min read
Press Releases
Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 14, 2025
·
10 min read
Press Releases
Sagimet Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 9, 2025
December 10, 2025
·
2 min read
Press Releases
Sagimet Biosciences Presents Two Denifanstat Posters at AASLD—The Liver Meeting® 2025
November 10, 2025
·
7 min read
Press Releases
Sagimet Biosciences Announces Upcoming Presentation at AASLD—The Liver Meeting® 2025
October 8, 2025
·
6 min read
1 of 4,010
Next
